Hemogenyx Pharmaceuticals Plc Stock Buy Hold or Sell Recommendation
| HOPHF Stock | USD 1.24 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Hemogenyx Pharmaceuticals Plc is 'Strong Sell'. Macroaxis provides Hemogenyx Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding HOPHF positions.
Check out Hemogenyx Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Hemogenyx and provide practical buy, sell, or hold advice based on investors' constraints. Hemogenyx Pharmaceuticals Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Hemogenyx |
Execute Hemogenyx Pharmaceuticals Buy or Sell Advice
The Hemogenyx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Hemogenyx Pharmaceuticals Plc. Macroaxis does not own or have any residual interests in Hemogenyx Pharmaceuticals Plc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Hemogenyx Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Hemogenyx Pharmaceuticals Trading Alerts and Improvement Suggestions
| Hemogenyx Pharmaceuticals is way too risky over 90 days horizon | |
| Hemogenyx Pharmaceuticals may become a speculative penny stock | |
| Hemogenyx Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Hemogenyx Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (5.1 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hemogenyx Pharmaceuticals Plc has accumulated about 6.84 M in cash with (2.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 13.0% of the company shares are held by company insiders |
Hemogenyx Pharmaceuticals current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Hemogenyx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Hemogenyx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Hemogenyx Pharmaceuticals Returns Distribution Density
The distribution of Hemogenyx Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Hemogenyx Pharmaceuticals' future price movements. The chart of the probability distribution of Hemogenyx Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Hemogenyx Pharmaceuticals Plc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Hemogenyx Pharmaceuticals returns is essential to provide solid investment advice for Hemogenyx Pharmaceuticals.
| Mean Return | 603.03 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 124.00 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Hemogenyx Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Hemogenyx Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Hemogenyx Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Hemogenyx Pharmaceuticals' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Hemogenyx pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 610.07 | |
β | Beta against Dow Jones | -278.46 | |
σ | Overall volatility | 128.88 | |
Ir | Information ratio | 0.12 |
Hemogenyx Pharmaceuticals Volatility Alert
Hemogenyx Pharmaceuticals Plc is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Hemogenyx Pharmaceuticals' pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Hemogenyx Pharmaceuticals' pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Hemogenyx Pharmaceuticals Fundamentals Vs Peers
Comparing Hemogenyx Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Hemogenyx Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Hemogenyx Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Hemogenyx Pharmaceuticals or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Hemogenyx Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Hemogenyx Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Hemogenyx Pharmaceuticals to competition |
| Fundamentals | Hemogenyx Pharmaceuticals | Peer Average |
| Return On Equity | -0.32 | -0.31 |
| Return On Asset | -0.18 | -0.14 |
| Current Valuation | 8.17 M | 16.62 B |
| Shares Outstanding | 1.14 B | 571.82 M |
| Shares Owned By Insiders | 13.01 % | 10.09 % |
| Price To Book | 1.78 X | 9.51 X |
| EBITDA | (2.39 M) | 3.9 B |
| Net Income | (5.1 M) | 570.98 M |
| Cash And Equivalents | 6.84 M | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Total Debt | 10.15 K | 5.32 B |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 20.23 X | 2.16 X |
| Book Value Per Share | 0.01 X | 1.93 K |
| Cash Flow From Operations | (2.63 M) | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Number Of Employees | 10 | 18.84 K |
| Beta | 3.49 | -0.15 |
| Market Capitalization | 45.68 M | 19.03 B |
| Total Asset | 8.52 M | 29.47 B |
| Net Asset | 8.52 M |
Hemogenyx Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Hemogenyx . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Hemogenyx Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Hemogenyx Pharmaceuticals Plc? Buying financial instruments such as Hemogenyx Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Hemogenyx Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Wireless Thematic Idea Now
Wireless
Companies providing wireless technology and communication services. The Wireless theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wireless Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Hemogenyx Pink Sheet
Hemogenyx Pharmaceuticals financial ratios help investors to determine whether Hemogenyx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hemogenyx with respect to the benefits of owning Hemogenyx Pharmaceuticals security.